Clinical Trials Directory

Trials / Unknown

UnknownNCT02839356

Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
670 (estimated)
Sponsor
Anhui Provincial Hospital · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) has been a well-recognized complication with significant morbidity and even mortality. A variety of possible mechanisms has been suggested in the occurrence of pancreatitis, but papillary edema caused by manipulations during cannulation or endoscopic treatment has received the most attention. The papillary edema may cause temporary outflow obstruction of pancreatic juice, and then increase ductal pressure, resulting in the occurrence of pancreatitis. Topical application of epinephrine on the papilla may reduce papillary edema. Moreover, it is reported that epinephrine sprayed on the papilla may be effective to prevent PEP. However, it is still unclear that epinephrine sprayed on the papilla can prevent acute pancreatitis after endoscopic retrograde cholangiopancreatography. We therefore designed a prospective randomized trial to determine whether epinephrine sprayed on the papilla prevent PEP after ERCP.

Detailed description

Between July 2016 and December 2017, 670 consecutive patients older than 18 years who are scheduled to undergo diagnostic or therapeutic ERCP at the Anhui Provincial Hospital will be recruited for the study. Patients were randomized using opaque, sealed envelopes containing random numbers assigning them to undergo a spray of epinephrine (epinephrine group) or saline (control group) on the major papilla. A two proportion equality test will be conducted to explore whether incidence rates are different. Descriptive statistics including number (N), mean, median, standard deviation, minimum and maximum, will be produced for all continuous variables. Frequency tables of number (N) and percentage of subjects will be produced for all categorical variables.

Conditions

Interventions

TypeNameDescription
DRUGepinephrine20-mL irrigation with epinephrine diluted to 0.02% in saline over the entire papilla
DRUGnormal saline20-mL irrigation with physiological saline over the entire papilla

Timeline

Start date
2016-07-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-07-21
Last updated
2017-03-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02839356. Inclusion in this directory is not an endorsement.